Click here to read the articles and download the PDF

Pharmaceutical Commerce - December 2024

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Did Industry Fumble the DSCSA Deadline?

A crash course on the bubble itself, including therapeutic areas most affected.

Going Inside the Gross-to-Net Bubble and Its Nuances

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Why AI Advances in CGT Require Getting Data Right

Articles

Causal mediation analysis sought to determine how public hesitancy plays a role in the government procurement of certain vaccines.

Public Sentiments Toward Purchasing Foreign Vaccines During a Pandemic 

Videos

In an interview with Pharma Commerce Editor Nicholas Saraceno, Lung-I Cheng, PhD, VP, Head of Cell & Gene Therapy Service Line, Cencora, offers his thoughts on industry pain points and where he envisions the market progressing in terms of its technological capabilities. 

Cencora VP & Head of Cell & Gene Therapy Service Line Discusses Industry Pain Points and Technological Capabilities

The latest news for pharma industry insiders.

Pharma Pulse 6/7/24: Mark Cuban Talks Drug Pricing, Cost Remains Barrier to Respiratory Care for Patients & more

Ashfield Event Experiences and WRG merge in an effort to better serve the healthcare industry. 

Introducing Emota: A New Inizio Engage Agency

Senior Director of Strategic Planning at Marken.

New innovations that are contributing to industry environmental efforts. 


Medicine for the Planet: Building a Sustainable Legacy in Pharma Supply Chains

If Congress doesn't act soon, it could result in more health inequities.


The Need to Make Telehealth Flexibilities Permanent

An analysis of the general medicine portion of the pharmacy market amid ensuing challenges.


Who Moved My Prescription? Part IV: The Rise of Cash Pharmacy

Pharma Pulse 6/6/24: OpenAI Insiders Warn of a ‘Reckless’ Race for Dominance, Three Ways to Close the Urgent Talent Gap & more

The development and manufacturing plant will be constructed in Texas, and is expected to become operational by Q1 2025.

New pDNA Facility in the Works for Bionova Scientific 

The courts reversed certain key guidance documents issued by the Health Resources and Services Administration for the 340B Program, which raises uncertainty.

Featured Content

Pharmaceutical Commerce - December 2024

Did Industry Fumble the DSCSA Deadline?

Going Inside the Gross-to-Net Bubble and Its Nuances

Why AI Advances in CGT Require Getting Data Right